163 related articles for article (PubMed ID: 18459045)
1. Correction of cortisol overreplacement ameliorates morbidities in patients with hypopituitarism: a pilot study.
Danilowicz K; Bruno OD; Manavela M; Gomez RM; Barkan A
Pituitary; 2008; 11(3):279-85. PubMed ID: 18459045
[TBL] [Abstract][Full Text] [Related]
2. [Growth hormone deficiency in adults: effects of replacement therapy on body composition and health-related quality of life].
Mesa J; Gómez JM; Hernández C; Picó A; Ulied A;
Med Clin (Barc); 2003 Jan; 120(2):41-6. PubMed ID: 12570912
[TBL] [Abstract][Full Text] [Related]
3. Baseline characteristics and effects of growth hormone therapy over two years in younger and elderly adults with adult onset GH deficiency.
Franco C; Johannsson G; Bengtsson BA; Svensson J
J Clin Endocrinol Metab; 2006 Nov; 91(11):4408-14. PubMed ID: 16940452
[TBL] [Abstract][Full Text] [Related]
4. Acute effect of increasing glucocorticoid replacement dose on cardiovascular risk and insulin sensitivity in patients with adrenocorticotrophin deficiency.
Petersons CJ; Mangelsdorf BL; Thompson CH; Burt MG
J Clin Endocrinol Metab; 2014 Jun; 99(6):2269-76. PubMed ID: 24606100
[TBL] [Abstract][Full Text] [Related]
5. Effects of 18-month of growth hormone (GH) replacement therapy in patients with Sheehan's syndrome.
Tanriverdi F; Unluhizarci K; Kula M; Guven M; Bayram F; Kelestimur F
Growth Horm IGF Res; 2005 Jun; 15(3):231-7. PubMed ID: 15921942
[TBL] [Abstract][Full Text] [Related]
6. Hypopituitarism in five PROP1 mutation siblings: long-lasting natural course and the effects of growth hormone replacement introduction in middle adulthood.
Doknic M; Gasic V; Stojanovic M; Pavlovic S; Marinkovic S; Miljic D; Pekic S; Manojlovic-Gacic E; Damjanovic D; Soldatovic I; Petakov M
Pituitary; 2020 Aug; 23(4):400-408. PubMed ID: 32415500
[TBL] [Abstract][Full Text] [Related]
7. The effects of growth hormone deficiency and replacement on glucocorticoid exposure in hypopituitary patients on cortisone acetate and hydrocortisone replacement.
Swords FM; Carroll PV; Kisalu J; Wood PJ; Taylor NF; Monson JP
Clin Endocrinol (Oxf); 2003 Nov; 59(5):613-20. PubMed ID: 14616886
[TBL] [Abstract][Full Text] [Related]
8. Baseline characteristics and effects of ten years of growth hormone (GH) replacement therapy in adults previously treated with pituitary irradiation.
Elbornsson M; Götherström G; Bengtsson BÅ; Johannsson G; Svensson J
Growth Horm IGF Res; 2013 Dec; 23(6):249-55. PubMed ID: 24103227
[TBL] [Abstract][Full Text] [Related]
9. The modulation of corticosteroid metabolism by hydrocortisone therapy in patients with hypopituitarism increases tissue glucocorticoid exposure.
Sherlock M; Behan LA; Hannon MJ; Alonso AA; Thompson CJ; Murray RD; Crabtree N; Hughes BA; Arlt W; Agha A; Toogood AA; Stewart PM
Eur J Endocrinol; 2015 Nov; 173(5):583-93. PubMed ID: 26264718
[TBL] [Abstract][Full Text] [Related]
10. Decreased quality of life (QoL) in hypopituitary patients: involvement of glucocorticoid replacement and radiation therapy.
Ajmal A; McKean E; Sullivan S; Barkan A
Pituitary; 2018 Dec; 21(6):624-630. PubMed ID: 30349995
[TBL] [Abstract][Full Text] [Related]
11. Sheehan's syndrome: baseline characteristics and effect of 2 years of growth hormone replacement therapy in 91 patients in KIMS - Pfizer International Metabolic Database.
Kelestimur F; Jonsson P; Molvalilar S; Gomez JM; Auernhammer CJ; Colak R; Koltowska-Häggström M; Goth MI
Eur J Endocrinol; 2005 Apr; 152(4):581-7. PubMed ID: 15817914
[TBL] [Abstract][Full Text] [Related]
12. Effects of 7 years of growth hormone replacement therapy in hypopituitary adults.
Chrisoulidou A; Beshyah SA; Rutherford O; Spinks TJ; Mayet J; Kyd P; Anyaoku V; Haida A; Ariff B; Murphy M; Thomas E; Robinson S; Foale R; Johnston DG
J Clin Endocrinol Metab; 2000 Oct; 85(10):3762-9. PubMed ID: 11061536
[TBL] [Abstract][Full Text] [Related]
13. GH replacement in hypopituitarism improves lipid profile and quality of life independently of changes in obesity variables.
Abrams P; Boquete H; Fideleff H; Feldt-Rasmussen U; Jönsson PJ; Koltowska-Häggström M; Wilton P; Abs R
Eur J Endocrinol; 2008 Dec; 159(6):825-32. PubMed ID: 18713841
[TBL] [Abstract][Full Text] [Related]
14. Ten-year GH replacement increases bone mineral density in hypopituitary patients with adult onset GH deficiency.
Götherström G; Bengtsson BA; Bosaeus I; Johannsson G; Svensson J
Eur J Endocrinol; 2007 Jan; 156(1):55-64. PubMed ID: 17218726
[TBL] [Abstract][Full Text] [Related]
15. Aspects of growth hormone deficiency and replacement in elderly hypopituitary adults.
Feldt-Rasmussen U; Wilton P; Jonsson P; ;
Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S51-8. PubMed ID: 15135778
[TBL] [Abstract][Full Text] [Related]
16. Baseline characteristics and the effects of two years of growth hormone replacement therapy in adults with growth hormone deficiency previously treated for Cushing's disease.
Johannsson G; Sunnerhagen KS; Svensson J
Clin Endocrinol (Oxf); 2004 May; 60(5):550-9. PubMed ID: 15104557
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease.
Fernholm R; Bramnert M; Hägg E; Hilding A; Baylink DJ; Mohan S; Thorén M
J Clin Endocrinol Metab; 2000 Nov; 85(11):4104-12. PubMed ID: 11095440
[TBL] [Abstract][Full Text] [Related]
18. The effect of growth hormone replacement on cortisol metabolism and glucocorticoid sensitivity in hypopituitary adults.
Weaver JU; Thaventhiran L; Noonan K; Burrin JM; Taylor NF; Norman MR; Monson JP
Clin Endocrinol (Oxf); 1994 Nov; 41(5):639-48. PubMed ID: 7828353
[TBL] [Abstract][Full Text] [Related]
19. Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database.
Abs R; Mattsson AF; Bengtsson BA; Feldt-Rasmussen U; Góth MI; Koltowska-Häggström M; Monson JP; Verhelst J; Wilton P;
Growth Horm IGF Res; 2005 Oct; 15(5):349-59. PubMed ID: 16168692
[TBL] [Abstract][Full Text] [Related]
20. Low-dose hydrocortisone replacement therapy is associated with improved bone remodelling balance in hypopituitary male patients.
Behan LA; Kelleher G; Hannon MJ; Brady JJ; Rogers B; Tormey W; Smith D; Thompson CJ; McKenna MJ; Agha A
Eur J Endocrinol; 2014 Jan; 170(1):141-50. PubMed ID: 24123094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
